Novo Integrated Sciences Inc Total Liabilities
Novo Integrated Sciences Inc total liabilities. Based on the latest financial reports, Novo Integrated Sciences Inc (NVOS) has total liabilities worth $17.53 Million USD as of November 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Novo Integrated Sciences Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Novo Integrated Sciences Inc (2004–2024)
Total liabilities of Novo Integrated Sciences Inc from 2004 to 2024. This chart illustrates how Novo Integrated Sciences Inc's total liabilities have evolved over time, based on quarterly financial data.
Novo Integrated Sciences Inc Competitors by Total Liabilities
The table below lists competitors of Novo Integrated Sciences Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Visionary Education Technology Holdings Group Inc.
NASDAQ:GV
|
USA | $58.43 Million |
|
Crimson Tide plc
LSE:TIDE
|
UK | GBX1.29 Million |
|
Dillistone Group PLC
LSE:DSG
|
UK | GBX2.49 Million |
|
Transense Technologies PLC
LSE:TRT
|
UK | GBX1.24 Million |
|
Eneraqua Technologies PLC
LSE:ETP
|
UK | GBX23.55 Million |
|
GSTechnologies Ltd
LSE:GST
|
UK | GBX44.64 Million |
|
Heavitree Brewery A
LSE:HVTA
|
UK | GBX5.16 Million |
Liability Composition Analysis (2004–2024)
This chart breaks down Novo Integrated Sciences Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Novo Integrated Sciences Inc.
Liquidity & Leverage Metrics
Novo Integrated Sciences Inc Total Liabilities Ratios Explained
Novo Integrated Sciences Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.37 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Novo Integrated Sciences Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Novo Integrated Sciences Inc (2004–2024)
The table below shows the annual total liabilities of Novo Integrated Sciences Inc from 2004 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-08-31 | $17.53 Million | +58.42% |
| 2023-08-31 | $11.06 Million | -59.57% |
| 2022-08-31 | $27.36 Million | +50.74% |
| 2021-08-31 | $18.15 Million | +211.98% |
| 2020-08-31 | $5.82 Million | -13.53% |
| 2019-08-31 | $6.73 Million | +47.24% |
| 2018-08-31 | $4.57 Million | -53.38% |
| 2017-08-31 | $9.80 Million | -1.65% |
| 2016-09-30 | $9.97 Million | +75869.89% |
| 2016-08-31 | $13.12K | -97.98% |
| 2015-08-31 | $648.26K | -50.35% |
| 2014-08-31 | $1.31 Million | +56.94% |
| 2013-08-31 | $831.89K | -64.66% |
| 2012-08-31 | $2.35 Million | -12.14% |
| 2011-08-31 | $2.68 Million | +78.83% |
| 2010-08-31 | $1.50 Million | +2.68% |
| 2009-08-31 | $1.46 Million | +57.43% |
| 2008-08-31 | $926.74K | +185.61% |
| 2007-08-31 | $324.47K | -21.15% |
| 2006-08-31 | $411.53K | -1.56% |
| 2005-08-31 | $418.04K | 0.00% |
| 2004-08-31 | $418.04K | -- |
About Novo Integrated Sciences Inc
Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates in two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, … Read more